Literature DB >> 32979559

Impaired cell migration and structural defects in myeloid cells overexpressing miR-30b and miR-142-3p.

Araceli Valverde1, Salvador Nares1, Afsar Raza Naqvi2.   

Abstract

Macrophages (MΦ) and dendritic cells (DC) play a fundamental role in shaping immune responses by sensing a plethora of Pathogen Associated Molecular Patterns (PAMPs), phagocytosis and antigen presentation to T lymphocytes. These important biological processes require efficient cell movement and an intact cellular morphology for dynamic interaction. The role of microRNAs (miRs) in this regard, however, is not well understood. In the present study, we show that miR-30b and miR-142-3p regulate migration and morphology of MΦ and DC. Transient overexpression of miR-30b and miR-142-3p attenuates migration and these cells display unique morphological deformities observed under electron microscopy. In addition, miR-142-3p overexpression in MΦ impaired phagocytosis of FITC-conjugated latex beads using live microscopy imaging. Interestingly, live cell imaging and F-actin staining revealed marked changes in the cell polarity and actin polymerization status, respectively. To identify miR-142-3p regulated pathways, we profiled global transcriptome changes in miR-142-3p or control mimic transfected DC. Expression of several genes were differentially altered by miR-142-3p and were associated with pathways related to cell movement, cell adhesion, and cytoskeletal rearrangement. Bioinformatics analysis identified a significant subset of downregulated genes with one or more predicted miR-142-3p binding sites in their 3'UTR strongly suggesting direct post-transcriptional impact of these miRNAs on multiple transcripts. Using dual luciferase assays, novel miR-142-3p binding sites were validated for three genes (Vinculin, Dab2 and Skap2) directly associated with cytoskeletal rearrangement and cell movement. In summary, our results show that miR-30b and miR-142-3p are regulators of myeloid cell cytoskeletal homeostasis and morphology.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cell migration; Cytoskeletal network; MicroRNA; Myeloid cells; Phagocytosis

Mesh:

Substances:

Year:  2020        PMID: 32979559      PMCID: PMC7686300          DOI: 10.1016/j.bbagrm.2020.194628

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  49 in total

Review 1.  MicroRNAs in stress signaling and human disease.

Authors:  Joshua T Mendell; Eric N Olson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

2.  MicroRNA-30a inhibits cell migration and invasion by downregulating vimentin expression and is a potential prognostic marker in breast cancer.

Authors:  Chun-Wen Cheng; Hsiao-Wei Wang; Chia-Wei Chang; Hou-Wei Chu; Cheng-You Chen; Jyh-Cherng Yu; Jui-I Chao; Huei-Fang Liu; Shian-Ling Ding; Chen-Yang Shen
Journal:  Breast Cancer Res Treat       Date:  2012-04-04       Impact factor: 4.872

3.  Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.

Authors:  George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-14       Impact factor: 11.205

Review 4.  Protective and pathogenic functions of macrophage subsets.

Authors:  Peter J Murray; Thomas A Wynn
Journal:  Nat Rev Immunol       Date:  2011-10-14       Impact factor: 53.106

5.  Most mammalian mRNAs are conserved targets of microRNAs.

Authors:  Robin C Friedman; Kyle Kai-How Farh; Christopher B Burge; David P Bartel
Journal:  Genome Res       Date:  2008-10-27       Impact factor: 9.043

6.  MicroRNAs responsive to Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis LPS modulate expression of genes regulating innate immunity in human macrophages.

Authors:  Afsar R Naqvi; Jezrom B Fordham; Asma Khan; Salvador Nares
Journal:  Innate Immun       Date:  2013-09-23       Impact factor: 2.680

7.  MiR-221 influences effector functions and actin cytoskeleton in mast cells.

Authors:  Ramon J Mayoral; Lorenzo Deho; Nicole Rusca; Nenad Bartonicek; Harpreet Kaur Saini; Anton J Enright; Silvia Monticelli
Journal:  PLoS One       Date:  2011-10-12       Impact factor: 3.240

8.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

9.  microRNA miR-142-3p Inhibits Breast Cancer Cell Invasiveness by Synchronous Targeting of WASL, Integrin Alpha V, and Additional Cytoskeletal Elements.

Authors:  Alexander Schwickert; Esther Weghake; Kathrin Brüggemann; Annika Engbers; Benjamin F Brinkmann; Björn Kemper; Jochen Seggewiß; Christian Stock; Klaus Ebnet; Ludwig Kiesel; Christoph Riethmüller; Martin Götte
Journal:  PLoS One       Date:  2015-12-10       Impact factor: 3.240

10.  miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells.

Authors:  Afsar Raza Naqvi; Jezrom B Fordham; Balaji Ganesh; Salvador Nares
Journal:  Sci Rep       Date:  2016-09-09       Impact factor: 4.379

View more
  3 in total

Review 1.  MicroRNAs as Regulators of Phagocytosis.

Authors:  Wojciech Gierlikowski; Barbara Gierlikowska
Journal:  Cells       Date:  2022-04-19       Impact factor: 7.666

Review 2.  MicroRNAs in shaping the resolution phase of inflammation.

Authors:  Raza Ali Naqvi; Meenal Gupta; Anne George; Afsar R Naqvi
Journal:  Semin Cell Dev Biol       Date:  2021-04-29       Impact factor: 7.727

3.  Long Non-coding RNAs RN7SK and GAS5 Regulate Macrophage Polarization and Innate Immune Responses.

Authors:  Imran Ahmad; Araceli Valverde; Raza Ali Naqvi; Afsar R Naqvi
Journal:  Front Immunol       Date:  2020-12-09       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.